Abstract:Background: Vitiligo is an autoimmune skin disorder primarily characterized by the absence of melanocytes, leading to the development of white patches on the patient's skin. Narrowband Ultraviolet B (NB-UVB) therapy is among the most effective approaches for stimulating the reformation of hyperpigmentation. This treatment utilizes a narrow spectrum of NBUVB wavelengths ranging from 311 to 313 nm to irradiate the affected area, thereby preventing the destruction of migrating and proliferating melanocytes. Nevertheless, the molecular alterations occurring in both the hair follicle and the interfollicular epidermis during NB-UVB treatment remain unknown. Methods: In this study, we conducted a comprehensive analysis of the consistency of differentially expressed genes (DEGs) within the enrichment pathways both before and after NB-UVB treatment, utilizing a bioinformatics approach. Furthermore, we employed CYTOHUBBA and Random Forest algorithms to identify and sequence hub genes from the pool of DEGs. Following validation of these hub genes through ROC curve analysis, we proceeded to construct an interaction network between these hub genes, miRNA, and drugs. Real-Time Quantitative Polymerase Chain Reaction (RT-qPCR) was used to further verify the difference in the expression of hub genes between the disease group and the control group. Results: Gene Set Enrichment Analysis of DEGs indicated strong associations with vitiligo in most pathways. Subsequently, we conducted Gene Ontology and Metascape enrichment analyses on the overlapping genes from DEGs. We identified key genes (COL11A1, IGFBP7, LOX, NTRK2, SDC2, SEMA4D, and VEGFA) within the Protein-Protein Interaction (PPI) network. We further explored potential drugs that could be used for the clinical treatment of vitiligo through the drug-hub gene interaction network. Finally, the results of RT-qPCR experiments demonstrated that the expression levels of the identified hub genes in both groups were consistent with the bioinformatics analysis results. method: The consistency of differentially expressed genes (DEGs) in the enrichment pathway before and after NB-UVB treatment was analyzed in detail from the perspective of bioinformatics. In addition, hub genes were screened and sequenced from DEGs based on CYTOHUBBA and Random Forest algorithms. After validating the hub genes based on ROC curve analysis, we also constructed the interaction network between the hub genes and miRNA and drugs. We also detected the hub genes by RT-qPCR. Conclusion: The hub genes obtained in this study may be a biomarker related to the development of vitiligo pigmentation. Our research not only contributes to a better understanding of the treatment mechanisms of vitiligo but also provides valuable insights for future personalized medical approaches and targeted therapies for vitiligo. conclusion: The hub genes obtained in this study may be a biomarker related to the development of vitiligo pigmentation.

Assessment of NB-UVB Effects on Skin of Atopic Dermatitis Patients: A Network Analysis

Efficacy Evaluation of Treatment of Psoriasis Via Narrow Band-Ultraviolet Radiation

Identification of Candidate Genes in Atopic Dermatitis Based on Bioinformatic Methods

Anti-TNF- Αtreatment-Related Pathways and Biomarkers Revealed by Transcriptome Analysis in Chinese Psoriasis Patients

Evaluation of Biological Effects and Transcriptome Changes Induced by LED-Based Narrow-Band UVB Phototherapy

Narrowband Ultraviolet B Interferes with Gene Expression in the Peripheral Blood T Cells of Patients with Psoriasis.

Assessment of Recovery Time Effects on Human Primary Neonatal Dermal Fibroblasts After Exposure to Solar-Simulated Ultraviolet Radiation

Integrative analysis of RNA-sequencing and microarray for the identification of adverse effects of UVB exposure on human skin

P035 Quantifying the mutation burden of a therapeutic course of narrowband ultraviolet B (UVB) to help inform on the carcinogenicity of narrowband UVB

PD06 (P035) Quantifying the mutation burden of a therapeutic course of narrowband ultraviolet B (UVB) to help inform on the carcinogenicity of narrowband UVB

Screening for Biomarkers Related to Pigmentation and Formation in Vitiligo

Role Of Vegf Receptors In Normal And Psoriatic Human Keratinocytes: Evidence From Irradiation With Different Uv Sources

Assessment of the Effect of Narrowband UVB and Broadband UVB on Mice Skin Using Optical Coherence Tomography

Effects of UVB on the Expression of Fibronectin and EDA/EDB in Human Dermal Fibroblasts

The effects of NB-UVB on the hair follicle-derived neural crest stem cells differentiating into melanocyte lineage in vitro

Effect of NB-UVB therapy on IL-6 and neopterin levels in patients with psoriasis

Landscape dynamic network biomarker analysis reveals the tipping point of transcriptome reprogramming to prevent skin photodamage

Changes in Lesional and Non-lesional Skin Microbiome During Treatment of Atopic Dermatitis.

Effects of NB-UVB on the expression of CCL22 in HaCaT cells

Changes in serum endocan and nesfatin-1 levels in patients with psoriasis vulgaris after phototherapy

Effects of narrow-band UVB in inducing the expression of heparin-binding epidermal-growth-factor-like growth factor mRNA in normal human keratinocytes